Life Science and Research

The growing life science (biotech) and research sector accounts for roughly one in four office project completions in the United States to date. Gemini Rosemont is uniquely positioned with strategic life science and research building investments in key, talent-attracting, tech-savvy markets.

Tech-centric primary and opportunity cities have experienced higher rent growth, lower vacancies, and larger property value increases than cities without tech concentrations.

Gemini Rosemont selects markets which benefit from strong tech employer concentrations and “ecosystems,” proximal to high-quality educational institutions, executive housing, and ample lifestyle/recreational opportunities.